A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group

A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group

At the crossroads of innovation and advanced technology, Alexza Pharmaceuticals is working to develop products for the acute treatment of underserved medical needs in neuroscience. With two significant Phase IIb clinical trials on the horizon, Alexza requires a Head of Clinical Operations & GCP Compliance to manage overall clinical operations within the company. To acquire a top industry expert for this role, Alexza retained The Chase Group to secure a passionate and strong clinical operations leader to lay the foundation for this role in the company. For more information, please contact karen@chasegroup.com.